Biogen (BIIB) Stock: Buy, Sell, or Hold?
Get Alerted When BIIB Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, BIIB is in a strong uptrend. The price is approaching resistance at $261.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Trading Range & Key Levels
Protect Your Profits
Holding BIIB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanInstitutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research FeedQuantitative Signal Breakdown
- BULLISH: Options cheap (IV 5th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($268.26)
- BULLISH: Expecting earnings turnaround to 8.1% growth with 10.6% revenue growth
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Share this live BIIB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BIIB)
Data refreshes hourly during market hours. Next update: 2:43 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is BIIB showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$312 | 52 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 64 BUY |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1463 | 40 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 47 HOLD |
|
JNJ
Johnson & Johnson |
BUY
23 analysts |
$279 | 47 HOLD |
Advanced BIIB Option Strategies
Professional options setups generated by AI based on today's BIIB price and gamma walls.